Spark Therapeutics and Genable Technologies Announce Collaboration

News   Mar 26, 2014

 
Spark Therapeutics and Genable Technologies Announce Collaboration
 
 
 
 

RELATED ARTICLES

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

News

TheFDA has changed its accelerated approval of blinatumomab (Blincyto®) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.

READ MORE

GWAS Reveals Genes Associated with Lean Body Mass

News

Findings could lead to future therapies to preserve muscle mass as we age.

READ MORE

Programming Cells with Computer-like Logic

News

Novel RNA nano-devices in living cells can sense and analyze multiple complex signals for future synthetic diagnostics and therapeutics.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE